Publications:86
- Home
- Profiles
Erik Langhoff, MD, PhD
- About Me
- Education & Certifications
- Research
- Locations
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Education
BA, Soro Academy
MD, University of Copenhagen, Faculty of Medicine
PhD, University of Copenhagen, Faculty of Medicine
, The Rockefeller
, Massachusetts General Hospital
Research
The Bronx VA is participating in a research study to explore the beneficial effect of lowering homocysteine levels in patients with chronic renal failure. Chronic renal failure is associated with elevated levels of homocysteine which can be significantly reduced by treatment with folate, B6, and B12. It is thought that elevated levels of homocysteine may lead to vascular events that cause increase risk of arterial thrombosis, coronary disease of cerebrovascular events. This study will follow these clinical endpoints. Dr. Langhoff's basic research interests are HIV-1, Cytomegalovirus, and Polyoma Virus.
Locations
Publications
Selected Publications
- Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure. Christina A. Del Guzzo, Arsenije Kojadinovic, Ravi R. Vinnakota, Larisa J. Geskin, Jessica C. Newman, Erik Langhoff, Yeun Hee A. Park, Susan E. Bates, Ali N. Dana. Oncologist
- Effectiveness of Complementary and Integrative Approaches in Promoting Engagement and Overall Wellness Toward Suicide Prevention in Veterans. Amanda Vitale, Lauren Byma, Shengnan Sun, Evan Podolak, Zhaoyu Wang, Sharon Alter, Hanga Galfalvy, Joseph Geraci, Erik Langhoff, Heidi Klingbeil, Rachel Yehuda, Fatemeh Haghighi, Ann Feder. Journal of Alternative and Complementary Medicine
- The VA and Non-VA Experience of Tracking Good Care. Erik Langhoff, Albert Siu, Kenneth Boockvar, Linda Bund, Jim Connell, William Hung. Population Health Management
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Langhoff has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Langhoff has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.